1. Home
  2. VYNE vs AWX Comparison

VYNE vs AWX Comparison

Compare VYNE & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • AWX
  • Stock Information
  • Founded
  • VYNE 2003
  • AWX 1998
  • Country
  • VYNE United States
  • AWX United States
  • Employees
  • VYNE N/A
  • AWX N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • AWX Environmental Services
  • Sector
  • VYNE Health Care
  • AWX Utilities
  • Exchange
  • VYNE Nasdaq
  • AWX Nasdaq
  • Market Cap
  • VYNE 12.3M
  • AWX 10.1M
  • IPO Year
  • VYNE 2018
  • AWX 1998
  • Fundamental
  • Price
  • VYNE $0.38
  • AWX $2.82
  • Analyst Decision
  • VYNE Buy
  • AWX
  • Analyst Count
  • VYNE 2
  • AWX 0
  • Target Price
  • VYNE $8.00
  • AWX N/A
  • AVG Volume (30 Days)
  • VYNE 1.7M
  • AWX 68.3K
  • Earning Date
  • VYNE 11-06-2025
  • AWX 11-07-2025
  • Dividend Yield
  • VYNE N/A
  • AWX N/A
  • EPS Growth
  • VYNE N/A
  • AWX N/A
  • EPS
  • VYNE N/A
  • AWX 0.05
  • Revenue
  • VYNE $524,000.00
  • AWX $79,712,000.00
  • Revenue This Year
  • VYNE N/A
  • AWX N/A
  • Revenue Next Year
  • VYNE N/A
  • AWX N/A
  • P/E Ratio
  • VYNE N/A
  • AWX $61.09
  • Revenue Growth
  • VYNE 6.29
  • AWX N/A
  • 52 Week Low
  • VYNE $0.28
  • AWX $2.10
  • 52 Week High
  • VYNE $4.30
  • AWX $5.43
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 55.03
  • AWX 49.59
  • Support Level
  • VYNE $0.35
  • AWX $2.62
  • Resistance Level
  • VYNE $0.40
  • AWX $2.99
  • Average True Range (ATR)
  • VYNE 0.03
  • AWX 0.14
  • MACD
  • VYNE 0.00
  • AWX 0.01
  • Stochastic Oscillator
  • VYNE 74.75
  • AWX 34.21

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: